Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02485795Unknown

Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management

Role: lead

NCT02480075Unknown

Observational Study Linking Genetic Variants With Clinical Outcomes in Pain Management

Role: lead

NCT02487888Not ApplicableUnknown

A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care

Role: lead

All 3 trials loaded